To be eligible for participation in this study, a patient-caregiver dyad must meet the following inclusion criteria: 1. The patient has received a diagnosis of probable or possible Alzheimer’s disease, related dementia and diabetes (ADRD-DM) and receives care at the Eskenazi Health or IU Health primary care clinics. 2. The patient has a caregiver who is willing to participate in the study. 3. The caregiver is at least 18 years of age and does not have visual impairment interfering with the use of a smartphone. 4. Both patient and caregiver are community-dwelling in Indiana. 5. If the patient with ADRD-DM lacks capacity to consent to research, he or she must have a legal representative to consent on his or her behalf. 6. If the patient lacks capacity to consent to research, he or she gives assent to research participation. 7. The caregiver reports seeing the individual with ADRD-DM most days of the week.

 

The following was listed for patients. There were no specific exclusion criteria for clinicians. Exclusion criteria include patient prior CGM use, terminal illness, and CGM manufacturer’s exclusion guidelines: dialysis, ascorbic acid supplements, implanted medical devices, a bleeding disorder, pre-existing arm skin lesions interfering with CGM usage, allergy to medical adhesives or isopropyl alcohol, or plans for imaging or high-frequency electrical heat (diathermy) treatment during the study period.